MedTrace Logo

The Effect of Rectal and Sublingual Misoprostol Administration in Postpartum or Intrapartum Haemorrhage at Elective Caesarean Delivery: a Randomized Controlled Trial

NCT01931410 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 618

Last updated 2014-02-25

No results posted yet for this study

Summary

The investigators hypothesis in this study is that administration of rectal and sublingual misoprostol decreases intrapartum and postpartum haemorrhage.

Conditions

  • ıntrapartum Haemorrhage
  • Postpartum Haemorrhage

Interventions

DRUG

Misoprostol

Sponsors & Collaborators

  • Istanbul Bakirkoy Maternity and Children Diseases Hospital

    lead OTHER_GOV

Principal Investigators

  • Berhan AŞICIOĞLU, M.D. · T.C.S.B. Kanuni Sultan Süleyman Research Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2014-01-31
Completion
2014-02-28

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01931410 on ClinicalTrials.gov